Cellectar Biosciences Inc (CLRB)
2.03
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 14:31
Cellectar Biosciences Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| September 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| September 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2007 | 0.00 |
| June 30, 2007 | 0.00 |
| March 31, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| September 30, 2006 | 0.00 |
| June 30, 2006 | 0.00 |
| March 31, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| September 30, 2005 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
| Chimerix Inc | 0.00 |
| Marinus Pharmaceuticals Inc | -1.196 |
| Jaguar Health Inc | 1.948 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 29.38M |
| Total Liabilities (Quarterly) | 17.00M |
| Shareholders Equity (Quarterly) | 12.38M |